Security
ACB · AURORA CANNABIS INC
ACBNASDAQCommon stockCurrentCIK 1683541Updated Sep 26, 2026
ACB price & chart
Loading TradingView…
NASDAQ:ACB on TradingView ↗About the company
Aurora is a global leader in medical cannabis, dedicated to improving lives through scientific expertise, proven performance, and a deep commitment to patient care. Aurora serves medical markets across Canada, Europe, Australia, and New Zealand with a portfolio of trusted, leading brands including Aurora®, MedReleaf®, Pedanios®, IndiMed™, San Raf®, and Whistler Medical Marijuana Corporation®. With world-class GMP-certified manufacturing facilities in Canada and Germany, and a team of industry-leading professionals, Aurora continues to expand its global footprint and deliver consistent, high-quality cannabis products with the purpose of Opening the World to Cannabis™.
In the news
No coverage from other publishers is available.
Financials
FY 2025 · CADSource
Source
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Profit or LossCAD | 1,591,000Source | -69,326,000Source | -1,717,979,000Source | -695,089,000Source |
| Additional Financial Items | ||||
| AdjustmentsForSharebasedPaymentsCAD | 11,524,000Source | 12,717,000Source | 13,757,000Source | 20,243,000Source |
| AdjustmentsForUnrealisedForeignExchangeLossesGainsCAD | -11,453,000Source | 105,000Source | -1,915,000Source | 3,420,000Source |
| GeneralAndAdministrativeExpenseCAD | 97,257,000Source | 92,222,000Source | 113,212,000Source | 119,437,000Source |
| GoodwillCAD | 43,871,000Source | 43,180,000Source | 0Source | 887,737,000Source |
| IncreaseDecreaseInWorkingCapitalCAD | -10,210,000Source | 15,627,000Source | -52,652,000Source | -397,000Source |
| InterestPaidClassifiedAsOperatingActivitiesCAD | 6,844,000Source | 11,700,000Source | 27,725,000Source | 34,157,000Source |
| PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivitiesCAD | 5,240,000Source | 5,627,000Source | 7,545,000Source | 5,416,000Source |
| ProceedsFromIssuingSharesCAD | 0Source | 37,926,000Source | 350,188,000Source | 666,026,000Source |
| ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodCAD | 5,488,000Source | 4,993,000Source | 0Source | — |
| ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivitiesCAD | — | — | 19,648,000Source | 19,241,000Source |
| RepaymentsOfBorrowingsClassifiedAsFinancingActivitiesCAD | 7,245,000Source | 3,042,000Source | 0Source | — |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Selling, General and Administrative ExpenseCAD | — | 144,159,000Source | 175,237,000Source | — |
| Total RevenueCAD | — | — | 221,339,000Source | 245,252,000Source |
| Additional Financial Items | ||||
| ApplicableTaxRatenumber | 0.27Source | 0.27Source | 0.27Source | 0.27Source |
| BasicEarningsLossPerShareCAD/shares | 0.04Source | -1.52Source | -7.99Source | — |
| CurrentTaxExpenseIncomeCAD | 7,808,000Source | 1,109,000Source | 52,000Source | 122,000Source |
| DeferredTaxExpenseIncomeCAD | -3,189,000Source | -1,663,000Source | -2,193,000Source | -6,443,000Source |
| DeferredTaxExpenseIncomeRecognisedInProfitOrLossCAD | — | — | — | -6,542,000Source |
| DepreciationAndAmortisationExpenseCAD | 9,080,000Source | 12,139,000Source | 48,602,000Source | 49,174,000Source |
| DepreciationPropertyPlantAndEquipmentIncludingRightofuseAssetsCAD | 27,445,000Source | — | — | — |
| DilutedEarningsLossPerShareCAD/shares | 0.04Source | -1.52Source | -7.99Source | — |
| FinanceCostsCAD | 8,420,000Source | 14,186,000Source | 71,813,000Source | 66,437,000Source |
| GainsLossesRecognisedWhenControlInSubsidiaryIsLostCAD | — | 0Source | 0Source | 0Source |
| GeneralAndAdministrativeExpenseCAD | 97,257,000Source | 92,222,000Source | 113,212,000Source | 119,437,000Source |
| GrossProfitCAD | 187,607,000Source | 131,460,000Source | 21,225,000Source | -21,558,000Source |
| ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipmentIncludingRightofuseAssetsCAD | 696,000Source | — | — | — |
| IncomeTaxExpenseContinuingOperationsCAD | 4,619,000Source | -554,000Source | -2,141,000Source | -6,321,000Source |
| InterestExpenseOnLeaseLiabilitiesCAD | 2,921,000Source | 3,152,000Source | 3,433,000Source | 4,597,000Source |
| ProfitLossAttributableToNoncontrollingInterestsCAD | — | — | -355,000Source | — |
| ProfitLossAttributableToOwnersOfParentCAD | — | — | -1,717,624,000Source | — |
| ProfitLossBeforeTaxCAD | 20,382,000Source | -59,599,000Source | -1,720,120,000Source | -699,798,000Source |
| ProfitLossFromOperatingActivitiesCAD | 4,948,000Source | -46,453,000Source | -231,449,000Source | -282,818,000Source |
| ResearchAndDevelopmentExpenseCAD | 3,676,000Source | 3,572,000Source | 10,389,000Source | 11,447,000Source |
| ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodCAD | — | — | 293,000Source | 509,000Source |
Filing attachments
ex991.htm · 6-K · 2026-09-24
Exhibit 99.1 Aurora Cannabis Files Application with Alberta Securities Commission to Protect Company Shareholders Having Identified Several Deficiencies in Curaleaf's Hostile Bid Disclosure NASDAQ | TSX: ACB Aurora has filed an application with the Alberta Securities Commission for an order requiring Curaleaf to comply with securities laws. Aurora intends to demonstrate that Curaleaf's Circular has not satisfied several regulatory requirements, impacting Aurora Shareholders, includin…
Read attachment ↗